Search

Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo®) and ipilimumab (Yervoy®) significantly increased overall survival versus treatment with sunitinib (Sutent®) alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) that were reported online today in the New England Journal of Medicine.

… Wednesday, March 21, 2018 Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo ® ) and ipilimumab (Yervoy ® ) significantly increased overall survival versus treatment with sunitinib (Sutent ® ) alone, according to new findings from researchers

An FDA-approved drug used to treat leukemia can serve as a temporary off switch for CAR T cells, MSK scientists have found.

… Wednesday, July 3, 2019 Summary Researchers at Memorial Sloan Kettering and University Hospital in Würzburg, Germany, have identified a simple way to temporarily switch off CAR T cells with a commonly used drug. The approach could potentially help doctors limit the sometimes-severe side effects of this

According to a new study from Memorial Sloan Kettering published June 24 in Nature Medicine, patients in active cancer treatment who develop COVID-19 infection don’t fare any worse than other hospitalized patients. Researchers say their findings suggest that no one should delay cancer treatment because of concerns about the virus.

… Wednesday, June 24, 2020 Background Mini Kamboj, MD Mini Kamboj, MD Ying Taur, MD, PhD Ying Taur, MD, PhD The characterization of COVID-19 in patients with cancer remains limited in published studies and nationwide surveillance analyses. Reports from China and Italy have raised the possibility that patients

Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning.

… Monday, August 11, 2025 According to a study co-led by researchers at Memorial Sloan Kettering Cancer Center (MSK), a new vaccine shows encouraging early results as a potential “off-the-shelf” treatment for patients with  pancreatic  or  colorectal cancer . Unlike individualized cancer vaccines, which

Lea sobre una vacuna terapéutica que podría ayudar a prevenir que ciertos casos de cáncer de páncreas y colorrectal vuelvan a aparecer.

… Monday, August 11, 2025 Según un estudio codirigido por investigadores del Memorial Sloan Kettering Cancer Center (MSK), una nueva vacuna muestra resultados iniciales prometedores como posible tratamiento ‘listo para usar’ para pacientes con cáncer de páncreas  o  colorrectal . A diferencia de las vacunas

Oncologic outcomes are similar with the use of a sentinel lymph node algorithm compared to performing a full pelvic and paraaortic lymph node dissection in node-negative patients with deeply invasive endometroid endometrial carcinoma.

… Monday, January 14, 2019 Oncologic outcomes are similar with the use of a sentinel lymph node (SLN) algorithm compared to performing a full pelvic and paraaortic lymph node dissection (LND) in node-negative patients with deeply invasive endometroid endometrial carcinoma (EEC), according to our recent

… Wednesday, May 2, 2018 Summary This story originally appeared in Bridges, our newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how to receive

Given the current pandemic, every time a healthcare provider asks a patient to come in for an appointment, they’re making a mental calculation of the risk and benefit. Utilizing telemedicine has allowed providers at Memorial Sloan Kettering (MSK) to keep patients safely sheltered at home, while continuing to provide their necessary care.

… Thursday, May 7, 2020 Going through treatment for cancer is almost like having a fulltime job. Patients can have multiple appointments, and it is not uncommon for some patients to have three or more visits a week. Given the current pandemic, every time a healthcare provider asks a patient to come in

Breast pathologist Edi Brogi explains what patients should know about breast cancer diagnosis, second opinions, and promising new developments in treating some of the most aggressive forms of the disease.

… Tuesday, November 14, 2017 Summary Edi Brogi, a breast pathologist, explains what patients should know about breast cancer diagnosis, second opinions, and promising new developments in treating some of the most aggressive forms of the disease. A breast cancer diagnosis often starts when a change is found

Meet Emily Herzlin, who teaches mindfulness and meditation at Memorial Sloan Kettering.

… Wednesday, October 25, 2017 Summary Emily Herzlin, who teaches meditation through MSK’s Integrative Medicine Service , offers insight into how it can help people with cancer, survivors, and caregivers. Can the simple acts of being still, noticing your thoughts, and focusing on your breath really be transformative